Urinary tract infections in healthy women: a revolution in management? by Del Mar, Chris
Del Mar BMC Family Practice 2010, 11:42
http://www.biomedcentral.com/1471-2296/11/42
Open Access COMMENTARY
BioMed  Central
© 2010 Del Mar; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons At-
tribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
Commentary Urinary tract infections in healthy women: a 
revolution in management?
Chris Del Mar
Abstract
Background: Urinary infection in otherwise healthy women has largely been a straightforward matter of diagnosis by 
identifying bacteria in the urine, and then cure by appropriate antibiotics. Recent research has shown this to be over-
simplified. Evaluation of methods of self-management of symptoms has been neglected.
Discussion: Firstly trial data show that women with what used to called 'urethral syndrome' (urinary symptoms but 
sterile urine) obtain relief from antibiotics. Other trial data have shown a surprisingly large placebo effect from the 
resolution of symptoms among women who feel their care has been 'positive'. In addition, data published this month 
in BMC Medicine show that non-steroidal anti-inflammatory (NSAID) drugs provide symptom relief to women with 
conventional infections (positive urine bacteriology) as much as antibiotics.
Conclusions: These recent findings provide an opportunity to consider how clinicians might change practice, and sets 
a new research agenda. We need to know (1) whether the effect of NSAIDs is replicable; (2) why some women in 
previous trials have had more symptoms if not treated with antibiotics sooner; (3) whether NSAIDs and antibiotics have 
an additive effect on relieving symptoms; (4) how we can harness the placebo effect better to assist out patients with 
this distressing and common complaint.
See research article http://www.biomedcentral.com/1741-7015/8/30
Introduction
Urinary infections are very common among otherwise
healthy women: a very high number experience symp-
toms and will have sought treatment before the age of 40.
Among the aetiological actors, being sexually active
seems to be the most important, both before and after
menopause [1-3]. Diabetes is a well-known risk factor [4].
There is little that can be done to prevent urinary infec-
tions in healthy women. Therefore most attention is
focussed on treating infections as they arise.
Although asymptomatic bacteriuria is a predictor for
an increased risk of subsequently experiencing symptom-
atic urinary infections later, there is not regarded as a
strong association enough to warrant screening [4]
(except in antenatal care, recurrent infections or anatom-
ical abnormality - not under consideration here).
Diagnosis
Diagnosis has been considered straightforward in the
past. The presence of bacteria on urine culture has been
regarded as the gold standard. There has been discussion
about the use of urine dipsticks (particularly with strips
for testing for nitrites and leukocyte esterase) to guide
treatment before results of cultures are returned. Urine
dipsticks are useful for ruling out disease [5,6], and there
has been a good argument for treating otherwise healthy
women with antibiotics empirically if dipsticks are posi-
tive [5].
If there were no bacteria found on culture, an infective
cause for the symptoms seemed unlikely. This led to the
generation of a new term for 'culture-negative symptoms
of urinary frequency, urgency and dysuria', called 'ure-
thral syndrome', regarded as difficult to treat [7].
Conventional treatment
Conventional treatment has principally focussed on erad-
icating bacterial causes. This seems on first consideration
to be entirely logical: the urine is normally sterile, and
symptoms of infection (frequency, and dysuria especially)
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are relieved after the bacteria have been cleared. Most
organisms (and Escherichia coli among the faecal bacteria
by far the most common) are responsive to cheap and
available antibiotics.
Consequently, the focus of interest in the medical liter-
ature has been on selecting the appropriate antibiotic, the
tension existing between ensuring the likelihood of effec-
tiveness of the antibiotic, and minimising antibiotic resis-
tance in the community.
This approach has been turned on its head by the sur-
prising finding of a randomised controlled trial (RCT) in
the recent past of women with symptoms of urinary
infection, but negative findings for bacteria in the urine
[8]. The RCT found benefit for symptoms with antibiotic
over no antibiotics - even when conventional wisdom had
held that they were not infected by bacteria (but had what
might have been called 'urethral syndrome' in the past)
[8].
On the other side of the coin, women with urinary
infections randomised to delay taking antibiotics by two
days suffer only about a day or two more of symptoms [9].
In other words, we can think of UTI as a spontaneously
remitting disease, if we use symptoms (rather than steril-
ity of the urine[10]) as the end-point, which is accelerated
by the use of antibiotics.
A prognosis study has shown that the psychological
state of the woman is important - those with 'somatisa-
tion' (exaggerated feelings of symptoms ) are likely to
overcome their symptoms slower, while those who per-
ceived the doctor to be positive about quickly overcoming
symptoms recovered faster [9].
Like so much in medicine, the arena is messy, with
many factors influencing recovery.
One thing is clear: whether treatment should be aimed
at eliminating bacteria from the urine or not, certainly
treatment of the symptoms warrants attention.
The evidence
This is then a fertile time to think about using symptoms
control rather than 'bacterial eradication' as an approach.
Urinary alkalinisers self management
It has been traditional to use urinary alkalinisers in the
past as symptomatic relief (by the simple expedient of
taking sodium or potassium bicarbonate or other alkaline
by mouth) [11]. This is remarkably poorly evaluated in
the medical literature [12]. An observational study found
symptom severity within each woman's illness was not
associated with increases in urinary pH, suggesting alka-
linising the urine is unlikely to reduce symptoms [12]. A
factorial randomised trial which randomised yielded no
difference to those randomised to advice to use bicarbon-
ate or not [5].
Cranberry juice self management
Although cranberry juice is a well used 'alternative and
complementary medicine' for urinary tract infection, and
there is weak and contradictory evidence it might act as a
preventive agent [13], there is insufficient good quality
trial evidence to support its use as a treatment [14]. One
good RCT has been published recently to suggest that it
is not [5].
Non-steroidal anti-inflammatory (NSAIDs) drugs
These are commonly used for pain and inflammatory
conditions, and, although NSAIDs have adverse effects,
they are regarded as sufficiently safe to be available in
most jurisdictions over-the-counter without prescription.
The pragmatic trial published this month in BMC Med-
icine by Bleidorn and colleagues [15] randomised antimi-
crobial treatment against symptomatic treatment (in the
form of a non-steroidal anti-inflammatory drug) for uri-
nary symptoms. The treatments were equivalent not just
in the outcome of symptoms (which might have been pre-
dicted), but in the outcome of subsequent urinary infec-
tions. Why is this revolutionary? Because it turns on its
head the notion that we should regard urinary infections
as primarily an infectious process that needs sterilisation
of the urine to effect resolution.
It used to be thought that urinary infections were suffi-
ciently unusual and bizarre to requite extermination of
the bacterial intruder. However two things have altered
this approach. Firstly we recognise that some people
(especially the elderly) often have bacteriuria with no ill
effect, including no symptoms: treating them with antibi-
otics achieves only bacterial resistance. More recently we
have come to realise that women who have urinary symp-
toms but no evidence of bacterial infection detected on
urinary dip-stick - women who would have accordingly
been denied antibiotics using traditional treatments -
benefit symptomatically from antibiotics [8]. Guidelines
have adjusted to this in some quarters[16] (but not
all[17]).
Conclusions
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